THE APPROVAL by the Scottish Medicines Consortium of a new treatment that will reduce and slow the symptoms of adults with early primary progressive multiple sclerosis (PPMS) has been welcomed by NHS Shetland and local MSP Beatrice Wishart.
Ocrelizumab (brand name Ocrevus) will help the progression of PPMS, a progressive, incurable and life-long disease with gradual worsening of symptoms.
Shetland has one of the highest rates of people living with MS in Scotland and the UK.
NHS Shetland principal pharmacist Mary McFarlane said: “After a number of years in development it is great that we now have the possibility of treating primary progressive multiple sclerosis (PPMS) with this medicine in Scotland.
“Around one in eight people diagnosed with multiple sclerosis will have the PPMS form which, unlike other forms, is unrelenting after onset. Ocrelizumab will help to delay the progression of disability and offer improved quality of life for patients.”
Wishart said the prevalence of MS in Shetland has a big impact on the community.
“This decision to allow Ocrelizumab to be used in the treatment of early primary progressive MS is therefore excellent news,” she said.
“While this new treatment won’t be appropriate for everyone, it does show that research into MS is paying off and offers hope that new drugs will be available in the future for other forms of the condition.
“Scotland is home to world class research that is looking into more ways that people can manage the symptoms of MS, with a view to eventually finding a cure.”
MS is a life-long condition in which the immune system attacks the brain or spinal cord causing symptoms such as fatigue, weakness and visual and memory problems.
“Organisations like MS Society Shetland offer invaluable support to those living MS in Shetland and their families. I would encourage anyone affected by MS to contact them and find out how they can benefit from their services,” Wishart added.
Become a supporter of Shetland News
Shetland News is asking its many readers to consider start paying for their dose of the latest local news delivered straight to their PC, tablet or mobile phone.
Journalism comes at a price and because that price is not being paid in today’s rapidly changing media world, most publishers - national and local - struggle financially despite very healthy audience figures.
Most online publishers have started charging for access to their websites, others have chosen a different route. Shetland News currently has over 540 supporters who are all making small voluntary financial contributions. All funds go towards covering our cost and improving the service further.
Your contribution will ensure Shetland News can: -
- Bring you the headlines as they happen;
- Stay editorially independent;
- Give a voice to the community;
- Grow site traffic further;
- Research and publish more in-depth news, including more Shetland Lives features.
If you appreciate what we do and feel strongly about impartial local journalism, then please become a supporter of Shetland News by either making a single payment or monthly subscription.
Support us from as little as £3 per month – it only takes a minute to sign up. Thank you.Support Shetland News